308GA and LT-α--em class="a-plus-plus">252AG polymorphisms. Results The carriers of the TNF-α-em class="a-plus-plus">308A allele more frequently had asthma as compared to patients homozygous for the TNF-α-em class="a-plus-plus">308 G allele. In 9 of 108 (8.3%) of LTα--em class="a-plus-plus">252AA carriers, tuberculosis infection has been documented, whereas there was no case of tuberculosis among patients, either homozygous or heterozygous for LTα +252 G alleles (p--.01). We never observed virus hepatitis among LTα--em class="a-plus-plus">252GA carriers. The genotypes TNF-α-em class="a-plus-plus">308GG -LT-α--em class="a-plus-plus">252AA and TNF-α-em class="a-plus-plus">308GA -LT-α--em class="a-plus-plus">252AG were unfavorable with regard to liver disease development (both p-lt;-.05). It was also shown that neutrophil elastase activity was higher in sputum specimens from high TNF producers with genotypes TNF-α-em class="a-plus-plus">308GA or LT-α--em class="a-plus-plus">252GG. In addition the carriers of such genotypes demonstrated a higher risk of osteoporosis development (p values were 0.011 and 0.017, respectively). Conclusions The carriers of genotypes, which are associated with higher TNF-α production, demonstrated increased frequency of asthma, higher levels of neutrophil elastase, and decrease of bone density. On the contrary, the carriers of genotypes associated with low TNF-α production showed a higher frequency of tuberculosis infection." />
TNF gene polymorphisms in cystic fibrosis patients: contribution to the disease progression
详细信息    查看全文
  • 作者：Galina Shmarina (1) (2)
    Alexander Pukhalsky (1)
    Nika Petrova (3)
    Ekaterina Zakharova (4)
    Lucine Avakian (1)
    Nikolai Kapranov (1)
    Vladimir Alioshkin (5)
  • 关键词：TNF ; Gene polymorphism ; Cystic fibrosis ; Inflammation ; Liver disease ; Osteoporosis ; Tuberculosis ; Asthma
  • 刊名：Journal of Translational Medicine
  • 出版年：2013
  • 出版时间：December 2013
  • 年：2013
  • 卷：11
  • 期：1
  • 全文大小：299KB
  • 参考文献：1. Xie T, Rowen L, Aguado B, Ahearn ME, Madan A, Qin S, Campbell RD, Hood L: Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. / Genome Res 2003, 13:2621-636. CrossRef
    2. Campbell RD, Trowsdale J: Map of the human MHC. / Immunol Today 1993, 14:349-52. CrossRef
    3. Bozzoni F, Beutler B: The tumor necrosis factor ligand and receptor families. / N Engl J Med 1996, 334:1717-725. CrossRef
    4. Locksley RM, Killeen N, Lenardo MJ: The TNF and TNF receptor superfamilies: integrating mammalian biology. / Cell 2001, 104:487-01. CrossRef
    5. Elewaut D, Ware CF: The unconventional role of LT alpha beta in T cell differentiation. / Trends Immunol 2007, 28:169-75. CrossRef
    6. Stanke F, Becker T, Kumar V, Hedtfeld S, Becker C, Cuppens H, Tamm S, Yarden J, Laabs U, Siebert B, Fernandez L, Macek M Jr, Radojkovic D, Ballmann M, Greipel J, Cassiman JJ, Wienker TF, Tümmler B: Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. / J Med Genet 2011, 48:24-1. CrossRef
    7. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K, Algire M, McWilliams R, Beck S, Hoover-Fong J, Hamosh A, Cutler D, Cutting GR: Heritability of lung disease severity in cystic fibrosis. / Am J Respir Crit Care Med 2007, 175:1036-043. CrossRef
    8. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, McKenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfeld AE: Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. / Tissue Antigens 1998, 52:359-67. CrossRef
    9. Allen RD: Polymorphism of the human TNF-α promoter -random variation or functional diversity? / Mol Immunol 1999, 36:1017-027. CrossRef
    10. Messer G, Spengler U, Jung MC, Honold G, Bl?mer K, Pape GR, Riethmüller G, Weiss EH: Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. / J Exp Med 1991, 173:209-19. CrossRef
    11. Abraham LJ, French MA, Dawkins RL: Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. / Clin Exp Immunol 1993, 92:14-8. CrossRef
    12. Hull J, Thomson AH: Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. / Thorax 1998, 53:1018-021. CrossRef
    13. Yarden J, Radojkovic D, De Boeck K, Macek M Jr, Zemkova D, Vavrova V, Vlietinck R, Cassiman JJ, Cuppens H: Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype. / Thorax 2005, 60:320-25. CrossRef
    14. Zhang DL, Li JS, Jiang ZW, Yu BJ, Tang XM, Zheng HM: Association of two polymorphisms of tumor necrosis factor gene with acute biliary pancreatitis. / World J Gastroenterol 2003, 9:824-28.
    15. Stuber F, Petersen M, Bokelmann F, Schade U: A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-a concentrations and outcome of patients with severe sepsis. / Crit Care Med 1996, 24:381-84. CrossRef
    16. Vissar L, Blout ER: The use of p-nitrophenyl N-tert-butyloxycarbonyl-L-alaninate as substrate for elastase. / Biochim Biophys Acta 1972, 268:257-60. CrossRef
    17. Pukhalsky AL, Shmarina GV, Kapranov NI, Kokarovtseva SN, Pukhalskaya D, Kashirskaja NJ: Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease. / Mediators Inflamm 2004, 13:111-17. CrossRef
    18. Bianchi ML: Osteoporosis in children and adolescents. / Bone 2007, 41:486-95. CrossRef
    19. Zhang Y, Zhang J, Tian C, Xiao Y, He C, Li X, Bogati A, Huang J, Fan H: The ?08 G/A polymorphism in TNF-α gene is associated with asthma risk: an update by meta- analysis. / J Clin Immunol 2011, 31:174-85. CrossRef
    20. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. / Allergy 2004, 59:469-78. CrossRef
    21. García-Elorriaga G, Carrillo-Montes G, Mendoza-Aguilar M, González-Bonilla C: Polymorphisms in tumor necrosis factor and lymphotoxin A in tuberculosis without and with response to treatment. / Inflammation 2010, 33:267-75. CrossRef
    22. Efrati O, Barak A, Modan-Moses D, Augarten A, Vilozni D, Katznelson D, Szeinberg A, Yahav J, Bujanover Y: Liver cirrhosis and portal hypertension in cystic fibrosis. / Eur J Gastroenterol Hepatol 2003, 15:1073-078. CrossRef
    23. Agrons GA, Corse WR, Markowitz RI, Suarez ES, Perry DR: Gastrointestinal manifestations of cystic fibrosis: radiologic-pathologic correlation. / RadioGraphics 1996, 16:871-93.
    24. Colombo C, Battezzati PM, Crosignani A, Morabito A, Costantini D, Padoan R, Giunta A: Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome. / Hepatology 2002, 36:1374-382.
    25. Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, Hissar S: Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease. / J Hepatol 2006, 44:856-63. CrossRef
    26. Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK: Association of TNF-β polymorphism with disease severity among patients infected with hepatitis C virus. / J Med Virol 2004, 72:60-5. CrossRef
    27. Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pe?a AS: Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). / Clin Exp Immunol 1996, 103:391-96. CrossRef
    28. Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, Bonilla-González E, Romero-Hidalgo S, Escamilla-Guerrero G, Cuevas F, Espinosa-Rosales F, Martínez-Aguilar NE, Gómez-Vera J, Baca V, Orozco L: Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. / Hum Immunol 2009, 70:251-56. CrossRef
    29. Li YF, Gauderman WJ, Avol E, Dubeau L, Gilliland FD: Association of tumor necrosis factor G-308A with childhood asthma and wheezing. / Am J Respir Crit Care Med 2006, 173:970-76. CrossRef
    30. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D: Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. / J Hepatol 1999, 31:242-47. CrossRef
    31. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. / Proc Natl Acad Sci USA 1997, 94:3195-199. CrossRef
    32. Corvol H, Beucher J, Bo?lle PY, Busson PF, Muselet-Charlier C, Clement A, Ratjen F, Grasemann H, Laki J, Palmer CN, Elborn JS, Mehta A: Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients. / J Cyst Fibros 2012, 11:63-7. CrossRef
  • 作者单位：Galina Shmarina (1) (2)
    Alexander Pukhalsky (1)
    Nika Petrova (3)
    Ekaterina Zakharova (4)
    Lucine Avakian (1)
    Nikolai Kapranov (1)
    Vladimir Alioshkin (5)

    1. Department of Cystic Fibrosis, Research Centre for Medical Genetics, 1 Moskvorechie Street, Moscow, 115478, Russia
    2. Laboratory of Cytokines, G. N. Gabrichevsky Institute of Epidemiology and Microbiology, Moscow, Russia
    3. Laboratory of Genetic Epidemiology, Research Centre for Medical Genetics, Moscow, Russia
    4. Laboratory of Metabolic Diseases, Research Centre for Medical, Moscow, Russia
    5. G. N. Gabrichevsky Institute of Epidemiology and Microbiology, Moscow, Russia
文摘
Background It is well known that the disease progression in cystic fibrosis (CF) patients may be diverse in subjects with identical mutation in CFTR gene. It is quite possible that such heterogeneity is associated with TNF-α and/or LT-α gene polymorphisms since their products play a key role in inflammation. The aim of the study was to investigate the possible roles of TNF gene polymorphisms in CF disease phenotype and progression. Methods 198 CF patients and 130 control subjects were genotyped for both TNF-α-em class="a-plus-plus">308GA and LT-α--em class="a-plus-plus">252AG polymorphisms. Results The carriers of the TNF-α-em class="a-plus-plus">308A allele more frequently had asthma as compared to patients homozygous for the TNF-α-em class="a-plus-plus">308 G allele. In 9 of 108 (8.3%) of LTα--em class="a-plus-plus">252AA carriers, tuberculosis infection has been documented, whereas there was no case of tuberculosis among patients, either homozygous or heterozygous for LTα +252 G alleles (p--.01). We never observed virus hepatitis among LTα--em class="a-plus-plus">252GA carriers. The genotypes TNF-α-em class="a-plus-plus">308GG -LT-α--em class="a-plus-plus">252AA and TNF-α-em class="a-plus-plus">308GA -LT-α--em class="a-plus-plus">252AG were unfavorable with regard to liver disease development (both p-lt;-.05). It was also shown that neutrophil elastase activity was higher in sputum specimens from high TNF producers with genotypes TNF-α-em class="a-plus-plus">308GA or LT-α--em class="a-plus-plus">252GG. In addition the carriers of such genotypes demonstrated a higher risk of osteoporosis development (p values were 0.011 and 0.017, respectively). Conclusions The carriers of genotypes, which are associated with higher TNF-α production, demonstrated increased frequency of asthma, higher levels of neutrophil elastase, and decrease of bone density. On the contrary, the carriers of genotypes associated with low TNF-α production showed a higher frequency of tuberculosis infection.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址：北京市海淀区学院路29号 邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700